Arvinas Inc (ARVN)
Healthcare
Biotechnology
8.10 $
+0.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Arvinas Inc (ARVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -274 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -19 | 5.1 | -16 | -41 | -90 | 559 | -274 | -348 | -259 | -274 | |
| 0.4 | 0.3 | 0.7 | 2.3 | 4.0 | 6.0 | 8.2 | 6.7 | 6.6 | 5.2 | |
| 0.5 | 0.2 | 12 | 20 | 30 | 57 | 76 | 72 | 88 | 44 | |
| 0.1 | 0.6 | 12 | 20 | 30 | 66 | 76 | – | – | – | |
| -5.6 | 28 | 13 | 7.2 | -5.9 | 678 | -83 | -44 | -141 | -234 | |
| 0.3 | 1.0 | 2.8 | 6.2 | 6.4 | 4.7 | 6.8 | 2.9 | 1.8 | 1.9 | |
| -20 | 21 | -180 | -93 | 164 | -1,314 | 243 | 204 | 35 | 408 | |
| – | – | 60 | 3.4 | – | – | – | – | – | – | |
| – | – | -3.4 | -0.6 | -29 | 14 | 4.7 | 0.0 | 0.0 | -92 | |
| -0.1 | -0.2 | 1.8 | -0.2 | – | 0.0 | 0.0 | 0.0 | -0.4 | -0.2 | |
| -0.1 | -0.2 | 168 | 140 | 505 | 279 | 4.7 | 375 | 7.9 | -91 | |
| -40 | 26 | -28 | 6.0 | 579 | -476 | -26 | 230 | -217 | 42 | |
| -20 | 4.1 | -19 | -47 | -96 | 555 | -280 | -351 | -261 | -276 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.